Topics
Glioblastoma | Treatment | Overview
Home > Publications > Topics > Glioblastoma > Treatment > Overview
*Obrador E, Moreno-Murciano P, Oriol-Caballo M, López-Blanch
R, Pineda B, Gutiérrez-Arroyo JL, Loras A, Gonzalez-Bonet
LG, Martinez-Cadenas C, Estrela JM, Marqués-Torrejón
MÁ.
Glioblastoma
Therapy: Past, Present and Future.
Int
J Mol Sci. 2024 Feb 21;25(5):2529. doi:
10.3390/ijms25052529. PMID:
38473776.
Review. ˍ
Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J,
Keniry M.
Emerging
Therapies for Glioblastoma.
Cancers
(Basel). 2024 Apr 12;16(8):1485. doi:
10.3390/cancers16081485. PMID:
38672566.
Review.
ˍ
Sadowski K, Jażdżewska A, Kozłowski J, Zacny A,
Lorenc T, Olejarz W.
Revolutionizing
Glioblastoma Treatment: A Comprehensive Overview of Modern
Therapeutic Approaches.
Int
J Mol Sci. 2024 May 26;25(11):5774. doi:
10.3390/ijms25115774. PMID:
38891962.
Review. ˍ
Nguyen
TTT, Greene LA, Mnatsakanyan H, Badr CE.
Revolutionizing
Brain Tumor Care: Emerging Technologies and Strategies.
Biomedicines.
2024 Jun 20;12(6):1376. doi:
10.3390/biomedicines12061376. PMID:
38927583. Review.
ˍ
McBenedict B, Hauwanga WN, Pogodina A, Singh G, Thomas A, Ibrahim
AMA, Johnny C, Lima Pessôa B.
Approaches
in Adult Glioblastoma Treatment: A Systematic Review of Emerging
Therapies.
Cureus.
2024 Aug 26;16(8):e67856. doi:
10.7759/cureus.67856. PMID:
39328617. Review. ˍ
Fukushima CM, de Groot J.
Updates
for newly diagnosed and recurrent glioblastoma: a review of recent
clinical trials.
Curr
Opin Neurol. 2024 Sep 13. doi:
10.1097/WCO.0000000000001320. PMID:
39258745. Review. ˍ
Saqib M, Zahoor A, Rahib A, Shamim A, Mumtaz H.
Clinical
and translational advances in primary brain tumor therapy with a
focus on glioblastoma-A comprehensive review of the literature.
World
Neurosurg X. 2024 Sep 21;24:100399. doi:
10.1016/j.wnsx.2024.100399.
PMID:
39386927. Review. ˍ
Valerius AR, Webb LM, Thomsen A, Lehrer EJ, Breen WG, Campian JL,
Riviere-Cazaux C, Burns TC, Sener U.
Review
of Novel Surgical, Radiation, and Systemic Therapies and Clinical
Trials in Glioblastoma.
Int
J Mol Sci. 2024 Sep 30;25(19):10570. doi:
10.3390/ijms251910570. PMID:
39408897. Review. ˍ
Khiabani NA, Doustvandi MA, Story D, Nobari SA, Hajizadeh M,
Petersen R, Dunbar G, Rossignol J.
Glioblastoma
therapy: State of the field and future
prospects.
Life
Sci. 2024 Nov 12;359:123227. doi:
10.1016/j.lfs.2024.123227. PMID:
39537100. Review˰ ˍ
**Schettini F, Pineda E, Rocca A, Buché V, Donofrio CA,
Mazariegos M, Ferrari B, Tancredi R, Panni S, Cominetti M, Di
Somma A, González J, Fioravanti A, Venturini S, Generali D.
Identifying the best treatment choice
for relapsing/refractory glioblastoma: a systematic review with
multiple Bayesian network meta-analyses.
Oncologist.
2024 Dec 14:oyae338. doi:
10.1093/oncolo/oyae338. PMID:
39674575. Interventional; Review; Meta-anallysis.
ˍ
Gautam M, Gabrani R.
Current
Combinatorial Therapeutic Aspects: The Future Prospect for
Glioblastoma Treatment.
Curr
Med Sci. 2024 Dec 19;44(6):1175-1184. doi:
10.1007/s11596-024-2950-7. PMID:
39695017. Review˰ ˍ
Sipos D, Raposa BL, Freihat O,
Simon M, Mekis N, Cornacchione P, Kovács Á.
Glioblastoma:
Clinical Presentation, Multidisciplinary Management, and Long-Term
Outcomes.
Cancers
(Basel). 2025 Jan 5;17(1):146. doi:
10.3390/cancers17010146. PMID:
39796773. Review. ˍ
Pediatric spinal cord
Da Cunha AHGB, Guerra PLN, da Silva ICS, Júnior DLB, de
Carvalho Júnior EV.
Comparative
analysis of treatment modalities for pediatric spinal cord
glioblastoma: insights from a meta-analysis.
Childs
Nerv Syst. 2025 Jan 15;41(1):91. doi:
10.1007/s00381-024-06729-6. PMID:
39812802. Meta-analysis˰
ˍ
IDH-wildtype
Pham J, Cote DJ, Kang K, Briggs RG, Gomez D, Prasad A, Daggupati
S, Sisti J, Chow F, Attenello F, Chen CC, Zada G.
Treatment
practices and survival outcomes for
IDH-wildtype glioblastoma patients according to MGMT promoter
methylation status:
insights from the U.S. National Cancer Database.
J
Neurooncol. 2025 Feb 5. doi:
10.1007/s11060-025-04952-y. PMID:
39907975. Observational study. ˍ